My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 113

    1.

    HIV-1 accessory protein Vpr inhibits the effect of insulin on the Foxo subfamily of forkhead transcription factors by interfering with their binding to 14-3-3 proteins: potential clinical implications regarding the insulin resistance of HIV-1-infected patients.

    Kino T, De Martino MU, Charmandari E, Ichijo T, Outas T, Chrousos GP.

    Diabetes. 2005 Jan;54(1):23-31.PMID: 15616007 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Human immunodeficiency virus type-1 accessory protein Vpr: a causative agent of the AIDS-related insulin resistance/lipodystrophy syndrome?

    Kino T, Chrousos GP.

    Ann N Y Acad Sci. 2004 Jun;1024:153-67. Review.PMID: 15265780 [PubMed - indexed for MEDLINE]Related articles

    3.

    Vpr protein of human immunodeficiency virus type 1 binds to 14-3-3 proteins and facilitates complex formation with Cdc25C: implications for cell cycle arrest.

    Kino T, Gragerov A, Valentin A, Tsopanomihalou M, Ilyina-Gragerova G, Erwin-Cohen R, Chrousos GP, Pavlakis GN.

    J Virol. 2005 Mar;79(5):2780-7.PMID: 15708996 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome.

    Sawaya BE, Khalili K, Gordon J, Taube R, Amini S.

    J Biol Chem. 2000 Nov 10;275(45):35209-14.PMID: 10931842 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Human immunodeficiency virus (HIV)-1 viral protein R suppresses transcriptional activity of peroxisome proliferator-activated receptor {gamma} and inhibits adipocyte differentiation: implications for HIV-associated lipodystrophy.

    Shrivastav S, Kino T, Cunningham T, Ichijo T, Schubert U, Heinklein P, Chrousos GP, Kopp JB.

    Mol Endocrinol. 2008 Feb;22(2):234-47. Epub 2007 Oct 11.PMID: 17932108 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity.

    Schmoll D, Walker KS, Alessi DR, Grempler R, Burchell A, Guo S, Walther R, Unterman TG.

    J Biol Chem. 2000 Nov 17;275(46):36324-33.PMID: 10960473 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins.

    Scheijen B, Ngo HT, Kang H, Griffin JD.

    Oncogene. 2004 Apr 22;23(19):3338-49.PMID: 14981546 [PubMed - indexed for MEDLINE]Related articles

    8.

    Protein kinase B-alpha inhibits human pyruvate dehydrogenase kinase-4 gene induction by dexamethasone through inactivation of FOXO transcription factors.

    Kwon HS, Huang B, Unterman TG, Harris RA.

    Diabetes. 2004 Apr;53(4):899-910.PMID: 15047604 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.

    BouHamdan M, Kulkosky J, Duan LX, Pomerantz RJ.

    J Hum Virol. 2000 Jan-Feb;3(1):6-15.PMID: 10774802 [PubMed - indexed for MEDLINE]Related articles

    10.

    Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 14-3-3-independent pathways.

    Cahill CM, Tzivion G, Nasrin N, Ogg S, Dore J, Ruvkun G, Alexander-Bridges M.

    J Biol Chem. 2001 Apr 20;276(16):13402-10. Epub 2000 Dec 20.PMID: 11124266 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics.

    Jacobs FM, van der Heide LP, Wijchers PJ, Burbach JP, Hoekman MF, Smidt MP.

    J Biol Chem. 2003 Sep 19;278(38):35959-67. Epub 2003 Jul 11.PMID: 12857750 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Regulation of T cell activation by HIV-1 accessory proteins: Vpr acts via distinct mechanisms to cooperate with Nef in NFAT-directed gene expression and to promote transactivation by CREB.

    Lahti AL, Manninen A, Saksela K.

    Virology. 2003 May 25;310(1):190-6.PMID: 12788643 [PubMed - indexed for MEDLINE]Related articles

    13.

    Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR.

    Daitoku H, Yamagata K, Matsuzaki H, Hatta M, Fukamizu A.

    Diabetes. 2003 Mar;52(3):642-9.PMID: 12606503 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence.

    Guo S, Rena G, Cichy S, He X, Cohen P, Unterman T.

    J Biol Chem. 1999 Jun 11;274(24):17184-92.PMID: 10358076 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression.

    Lochhead PA, Coghlan M, Rice SQ, Sutherland C.

    Diabetes. 2001 May;50(5):937-46.PMID: 11334436 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Raf-1 kinase targets GA-binding protein in transcriptional regulation of the human immunodeficiency virus type 1 promoter.

    Flory E, Hoffmeyer A, Smola U, Rapp UR, Bruder JT.

    J Virol. 1996 Apr;70(4):2260-8.PMID: 8642652 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a.

    Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, Yang JY, Zou Y, Bao S, Hanada N, Saso H, Kobayashi R, Hung MC.

    Cell. 2004 Apr 16;117(2):225-37. Erratum in: Cell. 2007 Jun 29;129(7):1427-8. PMID: 15084260 [PubMed - indexed for MEDLINE]Related articles

    18.

    The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling.

    Skurk C, Izumiya Y, Maatz H, Razeghi P, Shiojima I, Sandri M, Sato K, Zeng L, Schiekofer S, Pimentel D, Lecker S, Taegtmeyer H, Goldberg AL, Walsh K.

    J Biol Chem. 2005 May 27;280(21):20814-23. Epub 2005 Mar 21.PMID: 15781459 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    11,12-Epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by down-regulating p27Kip1.

    Potente M, Fisslthaler B, Busse R, Fleming I.

    J Biol Chem. 2003 Aug 8;278(32):29619-25. Epub 2003 May 28.PMID: 12773534 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D.

    Schmidt M, Fernandez de Mattos S, van der Horst A, Klompmaker R, Kops GJ, Lam EW, Burgering BM, Medema RH.

    Mol Cell Biol. 2002 Nov;22(22):7842-52.PMID: 12391153 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity